Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Clinical trial NCT03489369 · COMPLETED
Trial details
- NCT number
- NCT03489369
- Sponsor
- Symphogen A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2020-01-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.